A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma

NCT00002318 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

225

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections

Interventions

DRUG: Doxorubicin hydrochloride (liposomal)
DRUG: Bleomycin sulfate
DRUG: Vincristine sulfate
DRUG: Doxorubicin hydrochloride

Sponsor

Sequus Pharmaceuticals